Pathology spectrum of kidney damage in Hodgkin’s lymphoma,non-Hodgkin lymphoma/leukemia,and lymphoplasmacytic lymphoma in the real practice

Abstract

Background:

Kidney damage in lymphomas/leukemia’s presents with either acute kidney injury (AKI), chronic kidney disease (CKD), or both; and whilst AKI leads to evaluation often based on the clinical data, in some AKI and in almost all CKD cases kidney biopsy gives a clue to the diagnosis.

Methods:

A single center non-interventional retrospective study identified 36 patients with biopsy-proven kidney damage: 6 with Hodgkin’s lymphoma (HL), 18 with non-Hodgkin’s lymphoma/leukemia (NHL/CLL), and 12 with lymphoplasmacytic lymphoma (LPL).

Results:

Fifty-eight percent males and 42% females mean age 56.2 ± 17.4 years, presented with nephrotic syndrome in 47.2%, and with AKI in 11.1% of cases; 75% of patients diagnosed with CKD; in 13.9% AKI was superimposed on CKD. Patients with NHL/CLL presented with AKI significantly more often compared to HL and LPL—44% versus 16.6% versus 0 respectively. Monoclonal immunoglobulin (MIg) related glomerulopathies (GP) were found in 83.3% versus 16.6% cases in the LPL and NHL/CLL sub-groups, respectively (p = 0.013). Patterns of damage included intracapillary monoclonal deposition disease, light and heavy chain amyloidosis, monotypic membranous nephropathy (MN), cryoglobulinemic glomerulonephritis (GN) and C3-GN in the LPL; and monotypic MN and proliferative GN with MIg deposits in the NHL/CLL sub-groups respectively. Paraneoplastic GPs were found in 83.3%, 38.8%, and 16.6% of patients with HL, NHL/CLL, LPL, respectively (HL vs LPL, p < 0.001), and included minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and IgA-nephropathy in the HL; membranoproliferative GN, MN, and MCD in NHL/CLL; and FSGS in the LPL sub-groups. Tubulointerstitial damage revealed in NHL/CLL sub-group only, and found in every other case with 80% of lymphoid infiltration.

Conclusions:

Pattern glomerular damage depends on lymphoma type: paraneoplastic GPs are typical for HL, MIg-related GPs dominate in LPL, NHL/CLL presents mainly as paraneoplastic with single MIg-related patterns. Tubulointerstitial damage due to specific kidney infiltration attributable to NHL/CLL.

Keywords

Kidney biopsy lymphoma nephrotic syndrome paraneoplastic glomerulopathy monoclonal immunoglobulin-related glomerulopathy lymphoid infiltration

Get full access to this article

View all access options for this article.

References

Cohen

Rennke

Laubach

, et al. The spectrum of kidney involvement in lymphoma: a case report and review of the literature. Am J Kidney Dis 2010; 56: 1191–1196.

Luciano

Brewster

UC.

Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis 2014; 21(1): 27–35.

Da’as

Polliack

Cohen

, et al. Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 2001; 67: 158–164.

S-J

Chen

H-P

Chen

Y-H

, et al. Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy. PLoS One 2014; 9(4): e95190.

Wanchoo

Bernabe Ramirez

Barrientos

, et al. Renal involvement in chronic lymphocytic leukemia. Clin Kidney J 2018; 11(5): 670–680.

Kudose

Markowitz

GS.

Paraneoplastic glomerulopathy. J Onco-Nephrol 2019; 3(2): 61–69.

Swerdlow

Campo

Pileri

, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127(20): 2375–2390.

Audard

Larousserie

Grimbert

, et al. Minimal change nephrotic syndrome and classical Hodgkin’s lymphoma: report of 21 cases and review of the literature. Kidney Int 2006; 69(12): 2251–2260.

Cambier

J-F

Ronco

Onco-nephrology: glomerular diseases with cancer. Clin J Am Soc Nephrol 2012; 7: 1701–1712.

10.

Amarapurkar

Bou-Slaiman

Madrid

, et al. Paraneoplastic glomerular disease: the struggle is real. J Onco-Nephrol 2019; 3(1): 31–38.

11.

Ronco

PM.

Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 1999; 56: 355–377.

12.

Bergmann

Buchheidt

Waldherr

, et al. IgA nephropathy and Hodgkin’s disease: a rare coincidence. Case report and literature review. Am J Kidney Dis 2005; 45: e16–e19.

13.

Da Silva Junior

de Farias Pinho

, et al. Renal infiltration presenting as acute kidney injury in Hodgkin lymphoma : a case report and review of the literature. Leuk Res Rep 2018; 10: 41–43.

14.

Morton

Wang

Devesa

, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265–276.

15.

Favre

Courtellemont

Callard

, et al. Membranoproliferative glomerulonephritis, chronic lymphocytic leukemia, and cryoglobulinemia. Am J Kidney Dis 2010; 55(2): 391–394.

16.

Masani

Jhaveri

Fishbane

Update on Membranoproliferative GN. Clin J Am Soc Nephrol 2014; 9: 600–608.

17.

Kofman

Zhang

S-Y

Copie-Bergman

, et al. Minimal change nephrotic syndrome associated with Non-Hodgkin lymphoid disorders. Medicine 2014; 93(24): 350–358.

18.

Arampatzis

Giannakoulas

Liakopoulos

, et al. Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab. BMC Nephrol 2011; 12: 33–37.

19.

Zaidan

Terrier

Pozdzik

, et al. Spectrum and prognosis of noninfectious renal mixed cryoglobulinemic GN. J Am Soc Nephrol 2016; 27(4): 1213–1224.

20.

Sanghavi

Nicosia

Dong

, et al. Intracapillary monoclonal deposits disease due to B-cell non-Hodgkin lymphoma: a case report and review of the literature. J Onco-Nephrol 2018; 2(2-3): 102–106.

21.

Strati

Nasr

Leung

, et al. Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience. Haematologica 2015; 100: 1180–1188.

22.

Poitou-Verkinder

Francois

Drieux

, et al. The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma: a 25-year multicenter experience. PLoS One 2015; 10: e0119156.

23.

Ubukata

Hara

Nishizawa

, et al. Prevalence and mortality of chronic kidney disease in lymphoma patients. A large retrospective cohort study. Medicine 2018; 97(2): e9615.

24.

Audard

Georges

Vanhille

, et al. Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol 2008; 3(5): 1339–1349.

25.

Higgins

Nasr

Said

, et al. Kidney involvement of patients with Waldenström macroglobulinemia and other IgM-producing B cell lymphoproliferative disorders. Clin J Am Soc Nephrol 2018; 13: 1037–1046.

26.

Lee

Smith

Tanphaichitr

, et al. Waldenström’s macroglobulinemia and nephrotic syndrome with membranous nephropathy. Scand J Urol Nephrol 2011; 45(6): 473–477.

27.

Zand

Kattah

Fervenza

, et al. C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis 2013; 62(3): 506–514.

28.

Ravindran

Fervenza

Smith

RJH

, et al. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype. Kidney Int 2018; 94: 178–186.

29.

L-L

Z-Y

Wang

S-X

, et al. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis. BMC Nephrol 2019; 20: 459–469.

30.

Leung

Bridoux

Batuman

, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 2019; 15(1): 45–59.

31.

Gono

Yazaki

Fushimi

, et al. AH amyloidosis, associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment. Am J Kidney Dis 2006; 47(5): 908–914.

32.

Picken

MM.

Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis. Contrib Nephrol 2007; 153: 135–155.

33.

Miyazaki

Yazaki

Gono

, et al. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report. Amyloid 2008; 15(2): 125–128.